Universe Pharmaceuticals (UPC) Total Current Liabilities (2020 - 2026)

Universe Pharmaceuticals has reported Total Current Liabilities for 7 years, with the latest figure at $13.6 million in Q1 2026.

• Quarterly Total Current Liabilities changed N/A year-over-year to $13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (changed N/A YoY) and the FY2025 annual result came in at $13.2 million, down 99.94% from the prior year.
• Total Current Liabilities grew to $13.6 million in Q1 2026 per UPC's latest filing, from $13.2 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $20.3 billion in Q3 2024 and troughed at $10.2 million in Q1 2022.
• A 5-year average of $2.6 billion and a median of $13.7 million in 2023 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities surged 147584.19% in 2024, then tumbled 99.94% in 2025.
• Over 5 years, Total Current Liabilities stood at $13.1 million in 2022, then rose by 5.01% to $13.8 million in 2023, then soared by 147584.19% to $20.3 billion in 2024, then sank by 99.94% to $13.2 million in 2025, then rose by 3.58% to $13.6 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $13.6 million, $13.2 million, and $20.3 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.